Your session is about to expire
← Back to Search
AG10 for Cardiomyopathy
Study Summary
This trial will study the long-term effects of AG10 on people with heart failure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 trial • 49 Patients • NCT03458130Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your blood tests show dangerous abnormalities that could be risky for you.You are allergic to the study drug AG10 or any of its ingredients.You might need a heart transplant or a mechanical heart device in the next year.I am not currently taking specific medications like diflunisal or green tea extracts for ATTR.I am not pregnant or breastfeeding, or I agree to stop breastfeeding to participate.I understand the study and have given my consent to participate.I don't have any health issues that could make the trial unsafe for me.I agree to use effective birth control if there's any chance of pregnancy.
- Group 1: Open-Label
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does AG10 have the green light from the FDA?
"AG10's safety is based on data from Phase 2 trials, which means that while there is some evidence to support its safety, there is none yet to suggest it is an effective medication."
Are young adults eligible for this experiment?
"According to the study's eligibility requirements, patients between 18 and 90 years old are able to enroll. There are 14 clinical trials for people younger than this age bracket and 168 for those older."
Are there any restrictions on who is eligible to participate in this trial?
"The ideal candidate for this trial is somebody aged 18-90 that has a cardiomyopathy. Furthermore, it is mandatory that all participants are willing and able to commit to the study medication schedule as well as other potential requirements."
Is this trial looking for new participants?
"No, this particular study is not taking any more patients at the moment. The clinical trial was first posted on 8/8/2018 and was last edited on 9/15/2021 according to information found on clinicaltrials.gov. It is worth noting that there are 176 other trials presently recruiting patients."
Where are the trial sites located?
"So far, this study has recruited patients from Yale University, Northwestern University, and Brigham and Women's Hospital. There are 9 other locations where researchers are looking for participants."
Share this study with friends
Copy Link
Messenger